Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-24 2:34 pm Purchase | 2024-12-19 | 13D | Aadi Bioscience, Inc. AADI | ACUTA CAPITAL PARTNERS LLC | 1,921,297 7.800% | 373,216 (+24.11%) | Filing History |
| 2023-02-14 3:32 pm Sale | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -391,209 (Position Closed) | Filing History |
| 2023-02-14 3:29 pm Sale | 2022-12-31 | 13G | Jiya Acquisition Corp. JYAC | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -562,500 (Position Closed) | Filing History |
| 2023-02-14 3:26 pm Sale | 2022-12-31 | 13G | BCLS Acquisition Corp. BLSA | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -843,122 (Position Closed) | Filing History |
| 2022-02-15 2:51 pm Sale | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 391,209 5.900% | -24,290 (-5.85%) | Filing History |
| 2022-02-15 2:48 pm Purchase | 2021-12-31 | 13G | BCLS Acquisition Corp. BLSA | ACUTA CAPITAL PARTNERS LLC | 843,122 5.700% | 843,122 (New Position) | Filing History |
| 2022-02-15 2:43 pm Sale | 2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -863,100 (Position Closed) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -344,172 (Position Closed) | Filing History |
| 2021-09-07 5:25 pm Purchase | 2021-08-26 | 13D | Aadi Bioscience, Inc. AADI | ACUTA CAPITAL PARTNERS LLC | 1,548,081 7.300% | 1,548,081 (New Position) | Filing History |
| 2021-03-22 06:06 am Purchase | 2021-03-12 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 415,499 8.400% | 165,499 (+66.20%) | Filing History |
| 2021-02-16 06:14 am Purchase | 2020-12-31 | 13G | Catalyst Biosciences, Inc. CBIO | ACUTA CAPITAL PARTNERS LLC | 344,172 6.100% | 344,172 (New Position) | Filing History |
| 2021-02-16 06:14 am Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 250,000 5.400% | 250,000 (New Position) | Filing History |
| 2021-02-16 06:11 am Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | ACUTA CAPITAL PARTNERS LLC | 863,100 5.600% | 863,100 (New Position) | Filing History |
| 2021-02-16 06:11 am Purchase | 2020-12-31 | 13G | Jiya Acquisition Corp. JYAC | ACUTA CAPITAL PARTNERS LLC | 562,500 5.200% | 562,500 (New Position) | Filing History |